Skip to main content

Table 4 Crude and adjusted associations of plaque burden and angiogenesis inhibitor concentration

From: Association of circulating angiogenesis inhibitors and asymmetric dimethyl arginine with coronary plaque burden

Factor (median [IQR])

Unadjusted β (95 % CI)

P value

Adjusted β (95 % CI)

P value

Endostatin (per 100 ng/mL)

−0.16 (−0.04, 0.13)

0.28

0.00 (−0.03, 0.036)

0.97

ADMA (per 0.1 μmol/L)

0.02 (−0.03, 0.08)

0.39

0.03 (−0.02, 0.09)

0.25

Thrombospondin-2 (per 100 pg/mL)

0.02 (0.00, 0.01)

0.37

0.00 (0.00, 0.01)

0.62

Endoglin (per 1 ng/mL)

−0.01 (−0.07, 0.05)

0.81

0.01 (−0.05, 0.07)

0.81

Angiopoietin-2 (per 1 ng/mL)

0.00 (−0.03, 0.02)

0.69

0.01 (–0.02, 0.04)

0.44

  1. Association of inhibitor level with log transformed plaque burden